Atomo Diagnostics Ltd has released a press release.
Quarterly Activities/Appendix 4C Cash Flow Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Atomo Diagnostics
- Exclusive Licence for a Novel Liver Function Test on Pascal
- 2025 Appendix 4E and Annual Report
- Update on Indicated Pascal Supply for FebriDx
- Successful Placement from Share Purchase Plan Shortfall
- Atomo secures order for Pascal worth US$410,000 from Lumos
Later from Atomo Diagnostics
- Atomo Secures a Significant Order for HIV Self-Test
- Atomo Secures Australian Order for Supply of HIV Self-Tests
- Appendix 4D and Half Year Report ended 31 Dec 2025
- H1 FY26 Results Presentation
- Response to ASX Price Query
Follow Atomo Diagnostics into a list and get an email when it puts out news.
Follow Atomo Diagnostics